Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Adderall XR (Mixed Salts of a Single-Entity Amphetamine Product) Extended Release Tablets
Company: Shire Laboratories, Inc.
Application No.:  021303s001
Approval Date: 05/22/2002

 

Date created:  June 22, 2007

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-